Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control.
- DOI
- 10.3390/ph13030041
- Published
- 2020 Mar 5
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph13030041,
title = {Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control.},
author = {Carpéné C and Les F and Mercader J and Gomez-Zorita S and Grolleau JL and Boulet N and Fontaine J and Iglesias-Osma MC and Garcia-Barrado MJ},
year = {2020},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph13030041},
url = {https://doi.org/10.3390/ph13030041}
}RIS
TY - JOUR TI - Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control. AU - Carpéné C AU - Les F AU - Mercader J AU - Gomez-Zorita S AU - Grolleau JL AU - Boulet N AU - Fontaine J AU - Iglesias-Osma MC AU - Garcia-Barrado MJ PY - 2020 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph13030041 UR - https://doi.org/10.3390/ph13030041 ER -
APA
C, C., F, L., J, M., S, G., JL, G., N, B., J, F., MC, I., & MJ, G. (2020). Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph13030041
Source records
- pubmed · retrieved 2026-09-25T07:57:29.732Z